Chemical Compound
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-10-(4-amino-4-oxobutyl)-7-(2-amino-2-oxoethyl)-16-benzyl-13-[(2S)-butan-2-yl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-1-oxo-5-(propan-2-ylamino)pentan-2-yl]pyrrolidine-2-carboxamide
CAS Registry Number
876296-47-8
Primary record
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-10-(4-amino-4-oxobutyl)-7-(2-amino-2-oxoethyl)-16-benzyl-13-[(2S)-butan-2-yl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-1-oxo-5-(propan-2-ylamino)pentan-2-yl]pyrrolidine-2-carboxamide
- 库存
- 7,416 克
- 纯度
- 98.9 %
- CAS
- 876296-47-8
化合物标识与属性
- CAS
- 876296-47-8
- PubChem CID
- 53330936
- SMILES
- CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCCC(=O)N
- Canonical SMILES
- CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O
名称与同义词
- SELEPRESSIN
- selepresina
- selepressine
- selepressinum
- Selepressin [INN]
- Selepressin [USAN:INN]
- UNII-8P2T76M0SJ
- Cbz-Phe-Ala-CH2F
- Fe202158
- (Phe2
- 8P2T76M0SJ
- SELEPRESSIN [USAN]
- RefChem:182318
- Fe 202158
- SELEPRESSIN [WHO-DD]
- D0S3YN
- CHEMBL1817709
- DTXSID90236538
- 876296-47-8
- FE-202158
- orb1699333
- SCHEMBL19712230
- GTPL11454
- DTXCID20159029
- GLXC-22956
- BDBM50350870
- V1a agonist (septic shock), Ferring
- BAT-010400
- DB12495
- (Phe2,Ile3,Hgn4,Orn(iPr)8)vasopressin
- CID:53330936
- SID:202535699
- HY-105239
- CS-0025461
- 2-Phe-3-Ile-4-Hgn-8-Orn(iPr)-vasopressin
- Vasopressin 1a agonist (septic shock), Ferring
- (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-10-(4-amino-4-oxobutyl)-7-(2-amino-2-oxoethyl)-16-benzyl-13-[(2S)-butan-2-yl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-1-oxo-5-(propan-2-ylamino)pentan-2-yl]pyrrolidine-2-carboxamide
- C559490
- Glycinamide, L-cysteinyl-L-phenylalanyl-L-isoleucyl-6-oxo-L-lysyl-L-asparaginyl-L-cysteinyl-L-prolyl-n5-(1-methylethyl)-L-ornithyl-, cyclic (1-6)-disulfide
- Q21098876
- vasopressin, Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)-
- H-Cys(1)-Phe-Ile-hGln-Asn-Cys(1)-Pro-Orn(iPr)-Gly-NH2
- (2-L-PHENYLALANINE,3-L-ISOLEUCINE,4-(6-OXO-L-LYSINE), 8-(5-N-(PROPAN-2-YL)-L-ORNITHINE))HUMAN VASOPRESSIN
- vasopressin, phenylalanyl(2)-isoleucyl(3)-Hgn(4)-ornithyl(isopropyl)(8)-
- (2S)-1-((4R,7S,10S,13S,16S,19R)-19-amino-10-(4-amino-4-oxobutyl)-7-(2-amino-2-oxoethyl)-16-benzyl-13-((2S)-butan-2-yl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl)-N-((2S)-1-((2-amino-2-oxoethyl)amino)-1-oxo-5-(propan-2-ylamino)pentan-2-yl)pyrrolidine-2-carboxamide
- 1-{(4R,7S,10S,13S,16S,19R)-19-Amino-10-(4-amino-4-oxobutyl)-7-(2-amino-2-oxoethyl)-16-benzyl-13-[(2S)-butan-2-yl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl}-L-prolyl-N~5~-(propan-2-yl)-L-ornithylglycinamide